Taiwan FDA registration af9b133740f3b2ca0f5cfaf47078dd15

Ice Golden Xinyou blood glucose test tablets

TW: 愛思金鑫友血糖試片

Taiwan·Risk Class 2·Jinhong Medical Materials Technology Co., Ltd. Taoyuan Factory·Registered Dec 14, 2022 – Dec 14, 2027Active

Registration details

Analysis ID: af9b133740f3b2ca0f5cfaf47078dd15

Company information

Manufacturer: Jinhong Medical Materials Technology Co., Ltd. Taoyuan Factory
Manufacturer Country: Taiwan, Province of China
Authorized Representative: Ace Medical Technology Co., Ltd.

Product details

Intended Use: This product is an in vitro diagnostic medical device, used to quantitatively detect the glucose content in fresh fingertip microvascular whole blood or venous whole blood, fingertip microvascular whole blood is suitable for practitioners and self-testing, venous blood is only for professional use, venous blood is only for professional use, can not be used for diabetes diagnosis and screening.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1345 Glucose Test System
Import Information: QMS/QSD;; 國產

Dates and status

Registration Date: Dec 14, 2022
Expiry Date: Dec 14, 2027

About this record

Access comprehensive regulatory information for Ice Golden Xinyou blood glucose test tablets in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number af9b133740f3b2ca0f5cfaf47078dd15 and manufactured by Jinhong Medical Materials Technology Co., Ltd. Taoyuan Factory. The authorized representative in Taiwan is Ace Medical Technology Co., Ltd..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.